相关实验视频

Updated: Jul 26, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

miR-200a-3p通过向STAT4来预测预后并抑制膀癌细胞的增殖

Ming Li¹, Jie Li¹, Chaoyang Ye¹

¹Department of Urology, the Fifth People's Hospital of Dongguan, Dongguan, Guangdong Province, China.

Archives of medical science : AMS

|June 14, 2023

概括

微RNA-200a-3p (miR-200a-3p) 向STAT4,抑制膀癌 (BCa) 的进展. 对miR-200a-3p的下调和对STAT4的上调与BCa患者的预后不佳有关.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

STAT4是一种转录调节剂,在各种癌症中具有已知的致癌作用.
微RNA在癌症进展中的作用是一个活跃的研究领域.
膀癌 (BCa) 仍然是一个重要的健康问题,需要改进治疗目标.

研究的目的:

为了研究miR-200a-3p对膀癌中STAT4的转录后调节作用.
在BCa患者中评估miR-200a-3p和STAT4的预后意义.
在BCa中探索miR-200a-3p/STAT4轴的治疗潜力.

主要方法:

量化逆转录聚合酶链反应 (RT-qPCR) 和西部涂抹用于评估基因和蛋白质表达.
细胞增殖和细胞亡分别使用CCK-8和Annexin V-FITC测定法进行测量.
进行生物信息分析以预测和验证分子相互作用.

主要成果:

在BCa组织和细胞中,miR-200a-3p显著下调,而STAT4则上调.
在BCa患者中,miR-200a-3p和STAT4都作为总体和无病生存期的独立预后指标.
抑制STAT4抑制了BCa细胞生长并促进了细胞灭绝;miR-200a-3p直接向STAT4,抑制其蛋白质表达.

结论:

在膀癌的进展中,miR-200a-3p/STAT4信号通路至关重要.
STAT4作为miR-200a-3p的直接标,调解其瘤抑制作用.
针对miR-200a-3p/STAT4轴是一个有前途的治疗策略,用于膀癌.

关键词:

在STAT4中,我们使用了STAT4.膀癌:膀癌是一种癌症.在 miR-200a-3p 中.转录后的法规转录后的法规预后预后预后它们的扩散和扩散.

更多相关视频

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...